8-K/A

FORM 8-K AMENDMENT NO. 1

Company: Oncotelic Therapeutics, Inc.
Filed: October 1, 2013
Period of Report: September 18, 2013
Accession Number: 0001193125-13-386802

View Document ↗ View on SEC.gov ↗